CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.410
-0.250 (-6.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
CollPlant Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.65 | 10.96 | 0.3 | 15.64 | 6.14 | 2.32 | Upgrade
|
| Revenue Growth (YoY) | -93.94% | 3565.22% | -98.09% | 154.86% | 164.75% | -53.77% | Upgrade
|
| Cost of Revenue | 2.13 | 1.99 | 0.4 | 2.01 | 3 | 1.88 | Upgrade
|
| Gross Profit | -1.48 | 8.97 | -0.1 | 13.64 | 3.14 | 0.44 | Upgrade
|
| Selling, General & Admin | 5.78 | 6 | 6.74 | 5.94 | 4.67 | 3.66 | Upgrade
|
| Research & Development | 11.09 | 10.48 | 10.26 | 7.63 | 4.07 | 4.41 | Upgrade
|
| Operating Expenses | 16.87 | 16.48 | 17 | 13.57 | 8.73 | 8.07 | Upgrade
|
| Operating Income | -18.35 | -7.51 | -17.1 | 0.07 | -5.6 | -7.63 | Upgrade
|
| Interest Expense | - | - | -0.02 | -0.01 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 1.22 | 0.79 | 0.32 | 0.22 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.29 | -0.29 | -0.12 | -0.04 | -0.18 | -0.23 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.01 | -0.01 | -0 | 0.03 | -3.29 | Upgrade
|
| Pretax Income | -17.42 | -7.02 | -16.93 | 0.24 | -5.77 | -11.16 | Upgrade
|
| Net Income | -17.42 | -7.02 | -16.93 | 0.24 | -5.77 | -11.16 | Upgrade
|
| Net Income to Common | -17.42 | -7.02 | -16.93 | 0.24 | -5.77 | -11.16 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 10 | 7 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 12 | 7 | 5 | Upgrade
|
| Shares Change (YoY) | 1.19% | 3.23% | -7.80% | 73.76% | 38.12% | 13.73% | Upgrade
|
| EPS (Basic) | -1.52 | -0.62 | -1.53 | 0.02 | -0.84 | -2.24 | Upgrade
|
| EPS (Diluted) | -1.52 | -0.62 | -1.53 | 0.02 | -0.84 | -2.24 | Upgrade
|
| Free Cash Flow | -13.63 | -3.72 | -14.97 | 1.07 | -4.89 | -7.19 | Upgrade
|
| Free Cash Flow Per Share | -1.19 | -0.33 | -1.36 | 0.09 | -0.71 | -1.44 | Upgrade
|
| Gross Margin | -227.08% | 81.83% | -33.78% | 87.18% | 51.08% | 18.94% | Upgrade
|
| Operating Margin | -2822.31% | -68.55% | -5718.06% | 0.42% | -91.23% | -329.21% | Upgrade
|
| Profit Margin | -2680.00% | -64.05% | -5660.54% | 1.52% | -94.09% | -481.62% | Upgrade
|
| Free Cash Flow Margin | -2096.46% | -33.92% | -5007.36% | 6.86% | -79.65% | -310.35% | Upgrade
|
| EBITDA | -17.27 | -6.41 | -16.02 | 0.84 | -4.94 | -7.09 | Upgrade
|
| EBITDA Margin | - | -58.49% | - | 5.36% | -80.48% | - | Upgrade
|
| D&A For EBITDA | 1.08 | 1.1 | 1.08 | 0.77 | 0.66 | 0.54 | Upgrade
|
| EBIT | -18.35 | -7.51 | -17.1 | 0.07 | -5.6 | -7.63 | Upgrade
|
| EBIT Margin | - | -68.55% | - | 0.42% | -91.23% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.